SECURITIES AND EXCHANGE COMMISSION

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

May 14, 2002

(Date of earliest event reported)

SANGSTAT MEDICAL CORPORATION

(Exact name of Registrant as specified in its charter)

 

Delaware

0-22890

94-3076-069

(State of incorporation or organization)

(Commission File No.)

(IRS Employer Identification No.)

 

6300 Dumbarton Circle
Fremont, CA 94555

(Address of principal executive offices)

 

(510) 789-4300

(Registrant’s telephone number, including area code)

 

 



 

Item 5.

Other Events.

 

SangStat Medical Corporation (the “Company”) announced the election of Hollings C. Renton to its Board of Directors at the Company’s Annual Meeting of Stockholders held on May 14, 2002.  The Company issued a press release dated May 14, 2002, announcing the election of Mr. Renton, which is filed herewith as Exhibit 99.1.

 

Item 7.

Exhibits.

 

 

 

(a)           Not applicable

 

 

 

(b)           Not applicable

 

 

 

(c)           Exhibits

 

Exhibit No.

 

Description

99.1

 

Press release dated May 14, 2002

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

SANGSTAT MEDICAL CORPORATION

 

 

 

 

 

By:

/s/ Stephen G. Dance

 

 

Stephen G. Dance

Date:  May 22, 2002

 

Senior Vice President, Finance

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press release dated May 14, 2002

 

4